美国早发型子痫前期风险评估:智库会议总结
Gottesfeld-Hohler纪念基金会于2018年5月召开工作组会议,汇集专业学会专家,讨论子痫前期风险评估文献、指南、阿司匹林预防使用、成本效益及实施可行性,并识别知识空白与未来研究方向。
要点
- 阿司匹林可降低早产子痫前期风险,但预防目标人群尚无共识。
- 会议讨论美国与欧洲阿司匹林预防使用、成本效益及评估工具可行性。
- 识别子痫前期风险评估与预防的知识空白,需解决后方可改变实践。
核心结论
- 阿司匹林可有效降低早产子痫前期风险,但预防目标人群尚无共识。
- 需解决特定知识空白和未来研究方向后方可改变实践。
研究设计与样本
- 2018年5月Gottesfeld-Hohler纪念基金会组织工作组会议,汇集领先专业学会专家。
主要发现
- 讨论了子痫前期风险评估文献与趋势、当前专业指南、美欧阿司匹林预防使用、成本效益数据及不同评估工具与预防策略在美国的实施可行性。
- 识别了子痫前期风险评估和预防中需在实践改变前解决的知识空白与未来研究方向。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preeclampsia is responsible for significant maternal and neonatal morbidity and is associated with a substantial economic burden. Aspirin has been shown to be effective in decreasing the risk of preterm preeclampsia; however, there is no consensus on the target population for aspirin prophylaxis. In May 2018, the Gottesfeld-Hohler Memorial Foundation organized a working group meeting with the goal of identifying the optimal preeclampsia risk-assessment strategy and consequent intervention in the United States. The meeting brought together experts from the leading professional societies. We discussed available literature and trends in preeclampsia risk assessment, current professional guidelines for identifying women at risk for preeclampsia, prophylactic use of aspirin in the United States and Europe, cost-effectiveness data, and feasibility of implementation of different assessment tools and preventive strategies in the United States. We identified specific knowledge gaps and future research directions in preeclampsia risk assessment and prevention that need to be addressed before practice change.
引用
- Copel JA, Platt LD, Hobbins JC, et al. Gottesfeld-Hohler Memorial Foundation Risk Assessment for Early-Onset Preeclampsia in the United States: Think Tank Summary. Obstet Gynecol. 2020. PMID: 31809427. doi:10.1097/AOG.0000000000003582
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。